查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030304

一次性注射器市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、最終用途、地區和競爭格局分類，2021-2031年

Disposable Syringes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球一次性注射器市場預計將從 2025 年的 116.1 億美元成長到 2031 年的 151.5 億美元，複合年成長率為 4.54%。

這些由注射器主體、活塞和針頭組成的一次性醫療器械，用於注射和抽取液體。市場成長的主要促進因素是需要定期腸外營養的慢性病發生率不斷上升，以及國際感染疾病免疫宣傳活動運動的不斷擴大。此外，醫療機構對病人安全和感染預防的日益關注，特別是對交叉感染和針刺傷的關注，也推動了對安全型注射器的需求。根據國際糖尿病聯盟（IDF）發布的《2025年糖尿病地圖集》，20至79歲成年人中，11.1%（約九分之一）患有糖尿病，凸顯了全球對胰島素輸注裝置的巨大需求。

市場概覽
預測期 2027-2031
市場規模：2025年 116.1億美元
市場規模：2031年 151.5億美元
複合年成長率：2026-2031年 4.54%
成長最快的細分市場 傳統注射器
最大的市場 北美洲

另一方面，市場成長面臨的主要障礙是多個地區嚴格的法規結構。這種複雜的合規環境需要進行全面的產品評估和批准程序，導致研發成本上升，並延緩新型或改進型一次性注射器的商業化。此外，如何處理和處置這些一次性醫療器材所產生的大量醫療廢棄物，仍是全球醫療保健基礎設施面臨的物流和環境挑戰。

市場促進因素

全球一次性注射器市場的主要驅動力是感染疾病和慢性病發病率的不斷上升。自體免疫疾病、糖尿病和感染疾病等疾病需要定期使用注射藥物、診斷試劑或疫苗。根據聯合國愛滋病規劃署（UNAIDS）預測，到2024年，全球將有130萬人感染愛滋病毒。愛滋病是一種需要持續照護和治療的疾病，其治療通常涉及注射藥物，因此對注射器的需求持續穩定。這些持續存在的全球健康問題凸顯了一次性注射器在患者短期和長期管理中的重要作用，確保了市場的穩定成長。

國際免疫和疫苗舉措的持續擴大也是市場成長的催化劑。大規模公共衛生措施，例如控制流感、脊髓灰質炎和麻疹等疾病，都高度依賴一次性注射器來實現安全有效的疫苗接種。 2024年，全球疫苗免疫聯盟（Gavi）報告稱，在其支持的國家，已有超過7,200萬兒童透過常規免疫規劃接種了疫苗，這表明這些工作需要大量的注射器。除了持續旺盛的需求外，新型生技藥品和注射療法的進步也推動了市場的上升趨勢。此外，BD公司報告稱，截至2025年9月30日的會計年度總銷售額為218億美元，凸顯了推動該行業發展的領先醫療技術公司的巨大財力。

市場挑戰

多個地區嚴格的法規結構對全球一次性注射器市場的成長構成重大阻礙。這種複雜的合規環境要求進行全面的測試和核准程序，直接增加了研發成本，並延長了新型或改進型注射器產品的上市時間。這些嚴格的法規迫使企業在全面的文件編制和合規方面投入巨資，實際上擠佔了原本可用於潛在市場擴張和創新研發的資金。

這些監管壓力透過造成特定的營運和財務困難，限制了市場成長。根據歐洲醫療技術協會（MedTech Europe）的報告，到2024年，與認證和維護一次性注射器等醫療設備相關的成本將比之前的指南高出100%以上，嚴重影響製造商的財務狀況和投資潛力。此外，歐洲醫療技術協會2025年的一項調查顯示，選擇歐盟作為產品初始市場的主要醫療設備製造商數量減少了約33%，凸顯了合規壁壘如何阻礙了產品快速進入市場。冗長的核准流程意味著，到2025年中期，60%的醫療設備法規（MDR）申請從提交到最終認證將需要大約13到18個月的時間，這將導致患者所需的重要注射器材供應持續延誤。

市場趨勢

預填充式注射器的日益普及是一個值得關注的市場趨勢，其優勢在於能夠提高病人安全性、確保劑量精準，並提升醫護人員和病人自行給藥的便利性。預填充注射器減少了必要的準備步驟，降低了污染和給藥錯誤的風險，這對於敏感的疫苗和生物製藥尤其重要。這項技術變革滿足了多個醫療保健領域對便利給藥方式日益成長的需求。例如，2026年1月，全球醫療技術公司BD宣布投資1.1億美元，擴大其在美國的預填充式注射器生產規模，旨在加速GLP-1和生物製藥的給藥，並加強藥品供應網路。此類投資凸顯了該行業致力於擴大先進給藥裝置的生產，以滿足不斷成長的全球需求。

同時，日益增強的環保意識和旨在減少醫療廢棄物的監管要求，正推動人們更加關注永續注射器材料，這也對市場產生了影響。這一趨勢包括研發更環保的注射器製造和包裝材料，例如可回收聚合物和生物基塑膠。製造商正致力於開發新型材料，以在保持嚴格的無菌和安全標準的同時，降低對環境的影響。這種全面的產業轉型也體現在包裝創新上。正如2025年10月杜邦Tyvek永續醫療保健包裝獎所強調的那樣，貝朗公司對其手術托盤和局部麻醉包裝進行了更新，每年減少了64噸塑膠和4400磅紙張的使用。這些努力凸顯了醫療組件領域為促進醫療保健產業的環境循環，持續追求永續材料創新。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球一次性注射器市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類別（普通注射器、安全注射器）
    • 依用途（醫院/診所、門診部、診斷中心、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美一次性注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲一次性注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區一次性注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲一次性注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲一次性注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球一次性注射器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Gerresheimer AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • B. Braun SE
  • Cardinal Health, Inc.
  • Schott AG
  • Hindustan Syringes & Medical Devices Ltd
  • Nipro Corporation
  • Retractable Technologies Inc.
  • Terumo Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 5165

The Global disposable syringes market is anticipated to expand from USD 11.61 billion in 2025 to USD 15.15 billion by 2031, reflecting a compound annual growth rate of 4.54%. These essential, single-use medical instruments, which consist of a barrel, plunger, and needle, are utilized for fluid injection or aspiration. Market growth is predominantly fueled by the rising incidence of chronic ailments requiring regular parenteral treatments, coupled with the broadening scope of international vaccination campaigns against infectious illnesses. Additionally, the heightened focus on patient safety and infection prevention in medical facilities, especially regarding cross-contamination and needlestick injuries, drives the need for safety-engineered syringes. The International Diabetes Federation (IDF) Diabetes Atlas 2025 reports that 11.1% of adults between 20 and 79 years old, roughly 1 in 9 people, have diabetes, highlighting the immense global need for insulin delivery devices.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 11.61 Billion
Market Size 2031USD 15.15 Billion
CAGR 2026-20314.54%
Fastest Growing SegmentConventional Syringes
Largest MarketNorth America

Conversely, a major hurdle restricting market growth is the rigorous regulatory framework present in multiple regions. This intricate compliance environment requires thorough product evaluations and clearance procedures, which ultimately inflate development expenses and delay the commercialization of novel or improved disposable syringe designs. Furthermore, the handling and disposal of the massive amounts of medical waste produced by these single-use tools remain a persistent logistical and environmental issue for global healthcare infrastructures.

Market Driver

A major factor stimulating the global disposable syringes market is the escalating rate of infectious and chronic illnesses. Medical conditions like autoimmune diseases, diabetes, and infectious disorders require the regular use of injectable drugs, diagnostic substances, or vaccines. UNAIDS reported that 1.3 million individuals globally acquired HIV in 2024, a condition requiring continuous care and treatment that frequently includes injectable regimens, thus maintaining a steady need for syringes. These persistent global health issues highlight the indispensable nature of disposable syringes in both short-term and chronic patient management, ensuring steady market expansion.

The continuous growth of international immunization and vaccination initiatives serves as another primary market catalyst. Large-scale public health efforts designed to curb diseases such as influenza, polio, and measles depend heavily on disposable syringes for secure and effective vaccine administration. In 2024, Gavi, the Vaccine Alliance, noted that routine immunization programs in supported nations vaccinated over 72 million distinct children, illustrating the massive quantity of syringes needed for these efforts. This consistent, high-volume requirement, alongside pharmaceutical progress in novel biologics and injectable therapies, supports the market's upward trend. Additionally, BD reported a total revenue of $21.8 billion for the fiscal year ending September 30, 2025, emphasizing the immense financial scale of key medical technology companies driving this sector.

Market Challenge

Strict regulatory frameworks in multiple regions pose a formidable barrier to the advancement of the global disposable syringes market. This complicated compliance landscape dictates exhaustive testing and authorization procedures, directly escalating development expenses and extending the timeline for launching new or improved syringe innovations. These strict stipulations force companies to channel significant investments into comprehensive documentation and regulatory adherence, effectively reallocating funds away from potential market expansion and innovative research.

The weight of these regulations restricts market growth by imposing concrete operational and financial difficulties. MedTech Europe reported that in 2024, the expenses related to certifying and maintaining medical devices, such as disposable syringes, surged by 100% or more over prior guidelines, severely affecting the financial health and investment potential of manufacturers. Additionally, a 2025 survey by MedTech Europe revealed an approximate 33% decline in major device manufacturers choosing the EU for their initial product rollouts, highlighting how compliance obstacles discourage prompt market entries. Prolonged clearance schedules, where 60% of Medical Device Regulation (MDR) applications require about 13 to 18 months from submission to final certification as of mid-2025, continually postpone the availability of vital injection tools for patients.

Market Trends

The rising adoption of pre-filled syringes is a notable market trend, motivated by their ability to boost patient safety, guarantee precise dosages, and elevate convenience for medical professionals and self-administering patients. By reducing the necessary preparation steps, these pre-loaded devices lower the chances of contamination and dosage mistakes, which is especially important for delicate vaccines and biologics. This shift in technology caters to the increasing need for intuitive drug delivery methods across multiple medical fields. Demonstrating this trend, global medical technology firm BD revealed a $110 million investment in January 2026 to boost its U.S. manufacturing of prefillable syringes, aiming to expedite GLP-1 and biologic drug administration while reinforcing pharmaceutical supply networks. Such financial commitments highlight the sector's dedication to expanding the production of sophisticated delivery mechanisms to satisfy escalating worldwide needs.

Simultaneously, the market is being influenced by an increasing focus on sustainable syringe materials, driven by heightened ecological awareness and regulatory mandates aimed at cutting down medical waste. This movement includes researching and implementing greener options, like recyclable polymers and bio-based plastics, for syringe construction and packaging. Producers are working to develop novel materials that preserve strict sterility and safety standards while lowering their ecological impact. This comprehensive industry transformation is evident in packaging updates; as noted in the October 2025 DuPont Tyvek(R) Sustainable Healthcare Packaging Awards, B. Braun revamped its procedure tray and regional anesthesia packaging to cut 64 metric tons of plastic and 4,400 pounds of paper each year. These efforts emphasize the ongoing search for sustainable material innovations in medical components to promote environmental circularity within the healthcare sector.

Key Market Players

  • Gerresheimer AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • B. Braun SE
  • Cardinal Health, Inc.
  • Schott AG
  • Hindustan Syringes & Medical Devices Ltd
  • Nipro Corporation
  • Retractable Technologies Inc.
  • Terumo Corporation

Report Scope

In this report, the Global Disposable Syringes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Disposable Syringes Market, By Product

  • Conventional Syringes
  • Safety Syringes

Disposable Syringes Market, By End Use

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Diagnostic Centers
  • Others

Disposable Syringes Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Disposable Syringes Market.

Available Customizations:

Global Disposable Syringes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Disposable Syringes Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Conventional Syringes, Safety Syringes)
    • 5.2.2. By End Use (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Disposable Syringes Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Disposable Syringes Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Disposable Syringes Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Disposable Syringes Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End Use

7. Europe Disposable Syringes Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Disposable Syringes Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Disposable Syringes Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Disposable Syringes Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Disposable Syringes Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Disposable Syringes Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End Use

8. Asia Pacific Disposable Syringes Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Disposable Syringes Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Disposable Syringes Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Disposable Syringes Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Disposable Syringes Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Disposable Syringes Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Disposable Syringes Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Disposable Syringes Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Disposable Syringes Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Disposable Syringes Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End Use

10. South America Disposable Syringes Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Disposable Syringes Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Disposable Syringes Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Disposable Syringes Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Disposable Syringes Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Gerresheimer AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Baxter International Inc.
  • 15.3. Becton, Dickinson and Company
  • 15.4. B. Braun SE
  • 15.5. Cardinal Health, Inc.
  • 15.6. Schott AG
  • 15.7. Hindustan Syringes & Medical Devices Ltd
  • 15.8. Nipro Corporation
  • 15.9. Retractable Technologies Inc.
  • 15.10. Terumo Corporation

16. Strategic Recommendations

17. About Us & Disclaimer